US FDA lawyers urge no 'do-over' for Avastin breast cancer indication
09 August 2011
Donna Young
Please Login to read the full article.
09 August 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Hope not enough for Avastin in MBC; Hamburg explains withdrawal
- Poor efficacy undermines Genentech metastatic breast cancer indication for Avastin
- Hamburg’s hammer falls on Avastin; breast cancer use revoked
- Early Adcetris OK no surprise to SGEN after taking US FDA's advice
ANALYSIS
Other Informa Analysis
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
